Address
Doctor Molewaterplein 40
Rotterdam
Zuid Holland
3015 GD, The Netherlands
Contact
John Hays0031107032177
j.hays@erasmusmc.nl
Website
Microbial and AMR Development/Validation Partner
EMC offers potential access to a biobank of microbial isolates, as well as to clinical samples and patients.
Assist technology innovators in their bacterial, fungal and AMR technology development and validation
Technology:
Microorganisms:
Application:
Development stage:
- Infection prevention
- Antimicrobial stewardship
- Microbial diagnostics
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Parasites
- Yeasts
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Research
- Validation
- Development
- Market entry
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Academia
- Company
- Institute
- NGO
- Government
Partnering:
- Joint Venture
- License
- Co-develop
- Outsource
- Sell
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- STI
- BSI
- RTI
- GII
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
Many different types of collaborations are available upon request.
EMC is aiding the development and validation of technologies that lead the way in innovation.
Expertise available in many areas including bacterial, mycobacterial, fungal and parasitic pathogens, as well as hospital acquired infections.
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!